Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Orion OYJ - 11 Year Stock Price History | ORINY

Historical daily share price chart and data for Orion OYJ since 2014 adjusted for splits and dividends. The latest closing stock price for Orion OYJ as of September 01, 2025 is 39.69.
  • The all-time high Orion OYJ stock closing price was 41.50 on July 23, 2025.
  • The Orion OYJ 52-week high stock price is 41.60, which is 4.8% above the current share price.
  • The Orion OYJ 52-week low stock price is 21.05, which is 47% below the current share price.
  • The average Orion OYJ stock price for the last 52 weeks is 30.98.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
  
Orion OYJ Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2025 32.5435 22.3930 41.5000 22.3782 39.6900 83.78%
2024 22.0835 21.4825 27.5279 16.9328 21.5960 4.48%
2023 19.2062 23.9297 23.9297 17.6942 20.6708 -19.13%
2022 18.7319 18.3372 25.5608 16.5386 25.5608 39.66%
2021 18.3178 17.1971 19.5567 17.1971 18.3021 -4.05%
2020 20.4082 16.4358 22.6387 14.4418 19.0752 6.57%
2019 14.4151 13.2002 17.8993 12.1554 17.8993 41.47%
2018 12.1940 14.1865 14.1865 10.2738 12.6527 -1.80%
2017 16.8081 18.5510 22.1290 12.3209 12.8848 -11.59%
2016 13.2361 11.3145 14.5733 11.3145 14.5733 31.25%
2015 12.6080 13.5572 14.6730 10.8870 11.1031 5.61%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $11.203B $1.669B
Orion Oyj is a pharmaceutical company. It develops, manufactures and markets human and veterinary pharmaceuticals, active pharmaceutical ingredients and diagnostic tests. The company's core therapy consists of central nervous system disorders, oncology and respiratory. Its product pipeline includes inhaled Easyhaler(R) pulmonary drugs. Orion Oyj is headquartered in Espoo, Finland.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $72.041B 27.71
Zoetis (ZTS) United States $69.314B 25.15
Takeda Pharmaceutical (TAK) Japan $47.697B 9.73
Daiichi Sankyo, - (DSNKY) Japan $45.256B 23.19
BeOne Medicines - (ONC) Switzerland $33.543B 0.00
Sandoz Group AG (SDZNY) Switzerland $27.672B 0.00
Summit Therapeutics (SMMT) United States $17.605B 0.00
Merck (MKKGY) Germany $16.427B 10.68
Shionogi (SGIOY) Japan $14.649B 0.00
Neurocrine Biosciences (NBIX) United States $13.846B 41.30
United Therapeutics (UTHR) United States $13.747B 11.90
IPSEN (IPSEY) France $11.409B 0.00
Madrigal Pharmaceuticals (MDGL) United States $9.722B 0.00
Eisai (ESAIY) $8.913B 10.05
Corcept Therapeutics (CORT) United States $7.347B 61.70
Stevanato Group S.p.A (STVN) Italy $6.968B 41.09
Grifols, S.A (GRFS) Spain $6.855B 0.00
Ionis Pharmaceuticals (IONS) United States $6.796B 0.00
Ono Pharmaceutical (OPHLF) Japan $5.740B 19.71
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.436B 0.00
Soleno Therapeutics (SLNO) United States $3.596B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $3.003B 14.27
Crinetics Pharmaceuticals (CRNX) United States $2.919B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $2.709B 0.00
Hypermarcas (HYPMY) Brazil $2.686B 20.19
Procaps Group, S.A (PROCF) Luxembourg $2.557B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.520B 8.44
Centessa Pharmaceuticals (CNTA) United Kingdom $2.248B 0.00
Ocular Therapeutix (OCUL) United States $2.124B 0.00
Dyne Therapeutics (DYN) United States $1.919B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.744B 0.00
Guardian Pharmacy Services (GRDN) United States $1.673B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.578B 23.51
Ardelyx (ARDX) United States $1.533B 0.00
Harrow (HROW) United States $1.443B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $1.433B 0.00
Xeris Biopharma Holdings (XERS) United States $1.264B 0.00
Evotec AG (EVO) Germany $1.243B 0.00
Collegium Pharmaceutical (COLL) United States $1.222B 6.68
Enliven Therapeutics (ELVN) United States $1.201B 0.00
ARS Pharmaceuticals (SPRY) United States $1.148B 0.00
Cronos Group (CRON) Canada $0.996B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.836B 0.00
Akebia Therapeutics (AKBA) United States $0.833B 0.00
Elite Pharmaceuticals (ELTP) United States $0.735B 0.00
Theravance Biopharma (TBPH) United States $0.699B 57.83
Rigel Pharmaceuticals (RIGL) United States $0.697B 7.18
ProKidney (PROK) United States $0.695B 0.00
KalVista Pharmaceuticals (KALV) United States $0.678B 0.00
Organogenesis (ORGO) United States $0.653B 0.00
Relay Therapeutics (RLAY) United States $0.619B 0.00
Bioventus (BVS) United States $0.612B 14.80
Tourmaline Bio (TRML) United States $0.601B 0.00
Siga Technologies (SIGA) United States $0.601B 7.42
USANA Health Sciences (USNA) United States $0.583B 11.95
Xencor (XNCR) United States $0.580B 0.00
Nektar Therapeutics (NKTR) United States $0.568B 0.00
Savara (SVRA) United States $0.567B 0.00
Oruka Therapeutics (ORKA) United States $0.554B 0.00
Zevra Therapeutics (ZVRA) United States $0.509B 0.00
Esperion Therapeutics (ESPR) United States $0.448B 0.00
Nanobiotix S.A (NBTX) France $0.429B 0.00
Aquestive Therapeutics (AQST) United States $0.376B 0.00
Aldeyra Therapeutics (ALDX) United States $0.350B 0.00
Altimmune (ALT) United States $0.338B 0.00
Larimar Therapeutics (LRMR) United States $0.300B 0.00
Nature's Sunshine Products (NATR) United States $0.297B 19.37
4D Molecular Therapeutics (FDMT) United States $0.288B 0.00
Galectin Therapeutics (GALT) United States $0.274B 0.00
AleAnna (ANNA) United States $0.270B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.260B 0.00
Lexeo Therapeutics (LXEO) United States $0.259B 0.00
Korro Bio (KRRO) United States $0.217B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.214B 33.00
Lyell Immunopharma (LYEL) United States $0.213B 0.00
Aclaris Therapeutics (ACRS) United States $0.209B 0.00
Heron Therapeutics (HRTX) United States $0.207B 0.00
OmniAb (OABI) United States $0.196B 0.00
MediWound (MDWD) Israel $0.180B 0.00
Journey Medical (DERM) United States $0.176B 0.00
Innate Pharma SA (IPHYF) France $0.173B 0.00
China SXT Pharmaceuticals (SXTC) China $0.169B 0.00
MEI Pharma (MEIP) United States $0.160B 0.00
Achieve Life Sciences (ACHV) Canada $0.152B 0.00
Profound Medical (PROF) Canada $0.134B 0.00
Inhibikase Therapeutics (IKT) United States $0.134B 0.00
Avalo Therapeutics (AVTX) United States $0.122B 0.00
Protara Therapeutics (TARA) United States $0.120B 0.00
Avita Medical (RCEL) United States $0.116B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.115B 0.00
Cassava Sciences (SAVA) United States $0.110B 0.00
Surrozen (SRZN) United States $0.104B 0.00
Wellgistics Health (WGRX) United States $0.103B 0.00
Dominari Holdings (DOMH) United States $0.100B 0.00
Champions Oncology (CSBR) United States $0.094B 21.25
Cardiol Therapeutics (CRDL) Canada $0.090B 0.00
VAXART, INC (VXRT) United States $0.089B 0.00
BioNxt Solutions (BNXTF) Canada $0.083B 0.00
Assertio Holdings (ASRT) United States $0.080B 0.00
Arch Biopartners (ACHFF) Canada $0.080B 0.00
Pyxis Oncology (PYXS) United States $0.079B 0.00
Context Therapeutics (CNTX) United States $0.075B 0.00
PMV Pharmaceuticals (PMVP) United States $0.074B 0.00
Unicycive Therapeutics (UNCY) United States $0.074B 0.00
Nutriband (NTRB) United States $0.072B 0.00
Gain Therapeutics (GANX) United States $0.072B 0.00
Liminatus Pharma (LIMN) United States $0.071B 0.00
Prelude Therapeutics (PRLD) United States $0.068B 0.00
Vivani Medical (VANI) United States $0.068B 0.00
Metagenomi (MGX) United States $0.065B 0.00
Karyopharm Therapeutics (KPTI) United States $0.062B 0.00
DURECT (DRRX) United States $0.060B 0.00
Inotiv (NOTV) United States $0.058B 0.00
PolyPid (PYPD) Israel $0.053B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.053B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.052B 31.73
Rafael Holdings (RFL) United States $0.052B 0.00
Jupiter Neurosciences (JUNS) United States $0.051B 0.00
Fractyl Health (GUTS) United States $0.049B 0.00
FibroGen (FGEN) United States $0.048B 0.00
NRx Pharmaceuticals (NRXP) United States $0.046B 0.00
Plus Therapeutics (PSTV) United States $0.045B 0.00
Tempest Therapeutics (TPST) United States $0.044B 0.00
Telomir Pharmaceuticals (TELO) United States $0.043B 0.00
Klotho Neurosciences (KLTO) United States $0.043B 0.00
Century Therapeutics (IPSC) United States $0.042B 0.00
Acrivon Therapeutics (ACRV) United States $0.042B 0.00
ElectroCore (ECOR) United States $0.040B 0.00
Relmada Therapeutics (RLMD) United States $0.037B 0.00
Mural Oncology (MURA) Ireland $0.036B 0.00
SCYNEXIS (SCYX) United States $0.035B 0.00
Vivos Therapeutics (VVOS) United States $0.033B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.031B 0.00
Iterum Therapeutics (ITRM) Ireland $0.030B 0.00
CASI Pharmaceuticals (CASI) China $0.028B 0.00
Mangoceuticals (MGRX) United States $0.025B 0.00
Enlivex Therapeutics (ENLV) Israel $0.025B 0.00
Cosmos Health (COSM) United States $0.024B 0.00
Natural Alternatives (NAII) United States $0.023B 0.00
Citius Pharmaceuticals (CTXR) United States $0.023B 0.00
Scienture Holdings (SCNX) United States $0.020B 0.00
Incannex Healthcare (IXHL) Australia $0.019B 0.00
Mannatech (MTEX) United States $0.018B 0.00
Ainos (AIMD) United States $0.018B 0.00
BioLineRx (BLRX) Israel $0.016B 0.00
Lipocine (LPCN) United States $0.016B 0.00
ProPhase Labs (PRPH) United States $0.014B 0.00
TherapeuticsMD (TXMD) United States $0.013B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.012B 0.00
Lyra Therapeutics (LYRA) United States $0.012B 0.00
BioVie (BIVI) United States $0.011B 0.00
ESSA Pharma (EPIX) Canada $0.011B 0.00
Phio Pharmaceuticals (PHIO) United States $0.011B 0.00
Talphera (TLPH) United States $0.011B 0.00
Aptorum Group (APM) United Kingdom $0.011B 0.00
Ernexa Therapeutics (ERNA) United States $0.010B 0.00
Traws Pharma (TRAW) United States $0.010B 0.02
Kiora Pharmaceuticals (KPRX) United States $0.010B 0.00
Heatwurx (PCSA) United States $0.010B 0.00
CERo Therapeutics Holdings (CERO) United States $0.009B 0.00
Carisma Therapeutics (CARM) United States $0.009B 0.00
TNF Pharmaceuticals (TNFA) United States $0.009B 0.00
Addex Therapeutics (ADXN) Switzerland $0.008B 0.00
VYNE Therapeutics (VYNE) United States $0.008B 0.00
TransCode Therapeutics (RNAZ) United States $0.008B 0.00
Biomerica (BMRA) United States $0.008B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.008B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.007B 0.00
Indaptus Therapeutics (INDP) United States $0.007B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.007B 0.00
Nuvilex (PMCB) United States $0.006B 0.00
Vyome Holdings (HIND) United States $0.006B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.006B 0.00
Aditxt (ADTX) United States $0.005B 0.00
Alaunos Therapeutics (TCRT) United States $0.005B 0.00
Clearmind Medicine (CMND) Canada $0.005B 0.00
InMed Pharmaceuticals (INM) Canada $0.004B 0.00
Xenetic Biosciences (XBIO) United States $0.004B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
CDT Equity (CDT) United States $0.004B 0.00
Jaguar Animal Health (JAGX) United States $0.004B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.004B 0.00
Redhill Biopharma (RDHL) Israel $0.003B 0.00
Qualigen Therapeutics (QLGN) United States $0.003B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.003B 0.00
PainReform (PRFX) Israel $0.003B 0.00
SHINECO (SISI) China $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
Universe Pharmaceuticals INC (UPC) China $0.002B 0.00
SciSparc (SPRC) Israel $0.001B 0.00
Indivior (INDV) United States $0.000B 13.64
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Minerva Neurosciences (NERV) United States $0.000B 1.59
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00